CEO: Gaurav Shah

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Rocket Pharmaceuticals Inc, formerly Inotek Pharmaceuticals Corp, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.


Key numbers

Market Capitalization:1227920980
Shares Outstanding: 54769000
Float: 51542723
Next Earning Date:2020-03-04
TTm EPS: -1.8484
TTm Dividend Rate:
200 days moving average:15.96
50 days moving average: 20.73
One day percent Change: 3.7



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,